Edition:
India

Elanco Animal Health Inc (ELAN.N)

ELAN.N on New York Stock Exchange

25.77USD
14 Aug 2020
Change (% chg)

$1.33 (+5.44%)
Prev Close
$24.44
Open
$24.35
Day's High
$26.44
Day's Low
$24.35
Volume
1,123,369
Avg. Vol
1,092,912
52-wk High
$32.65
52-wk Low
$15.17

Latest Key Developments (Source: Significant Developments)

Elanco Animal Health Says Co and Elanco US Entered Agreement Relating To Senior Secured First Lien Term Loan Of $4,275 Mln With Maturity Of 7 Years
Tuesday, 4 Aug 2020 

Aug 3 (Reuters) - Elanco Animal Health Inc ::ELANCO ANIMAL HEALTH - ELANCO, ELANCO US INC ENTERED AGREEMENT RELATING TO SENIOR SECURED FIRST LIEN TERM LOAN OF $4,275 MILLION WITH MATURITY OF 7 YRS.ELANCO ANIMAL HEALTH - ELANCO, ELANCO US INC ENTERED SENIOR SECURED FIRST LIEN REVOLVING CREDIT FACILITY OF UP TO $750 MILLION WITH MATURITY OF 5 YRS.ELANCO ANIMAL HEALTH - ON JULY 31, 2020, ELANCO TERMINATED ITS REVOLVING LOAN CREDIT AGREEMENT, DATED AS OF SEPTEMBER 5, 2018.  Full Article

Elanco Receives U.S. Federal Trade Commission Approval For Acquisition Of Bayer Animal Health
Wednesday, 15 Jul 2020 

Elanco Animal Health Inc ::ELANCO RECEIVES U.S. FEDERAL TRADE COMMISSION APPROVAL FOR ACQUISITION OF BAYER ANIMAL HEALTH.ELANCO ANIMAL HEALTH INC - DEAL ON TRACK FOR CLOSING AT BEGINNING OF AUGUST.  Full Article

UK's CMA Launches Inquiry Into Dechra Pharma-Elanco Merger
Monday, 20 Apr 2020 

April 20 (Reuters) - UK's Competition & Markets Authority::UK'S CMA - LAUNCH OF MERGER INQUIRY BY NOTICE TO DECHRA PHARMACEUTICALS/ELANCO DEAL ON 20 APRIL 2020.  Full Article

Elanco Animal Health Announces Upsizing And Pricing Of Common Stock And Pricing Of Tangible Equity Unit Offerings
Thursday, 23 Jan 2020 

Jan 23 (Reuters) - Elanco Animal Health Inc ::ELANCO ANIMAL HEALTH ANNOUNCES UPSIZING AND PRICING OF COMMON STOCK AND PRICING OF TANGIBLE EQUITY UNIT OFFERINGS.ELANCO ANIMAL HEALTH - ANNOUNCED CONCURRENT PUBLIC OFFERINGS OF 22.7 MILLION SHARES OF ITS COMMON STOCK AT $32.00 PER SHARE.ELANCO ANIMAL HEALTH - PRICED 11 MILLION OF 5.00% TANGIBLE EQUITY UNITS, WITH A STATED AMOUNT OF $50 PER UNIT.ELANCO ANIMAL HEALTH - COMMON STOCK OFFERING WAS UPSIZED FROM PREVIOUSLY ANNOUNCED OFFERING SIZE OF 19.2 MILLION SHARES OF COMMON STOCK.  Full Article

Elanco Animal Health Announces Common Stock And Tangible Equity Unit Offerings
Wednesday, 22 Jan 2020 

Jan 21 (Reuters) - Elanco Animal Health Inc ::ELANCO ANIMAL HEALTH ANNOUNCES COMMON STOCK AND TANGIBLE EQUITY UNIT OFFERINGS ASSOCIATED WITH FINANCING ACQUISITION OF BAYER’S ANIMAL HEALTH BUSINESS.ELANCO ANIMAL HEALTH INC - INTENDS TO MAKE CONCURRENT PUBLIC OFFERINGS OF 19.2 MILLION SHARES AND 11 MILLION TANGIBLE EQUITY UNITS.ELANCO ANIMAL HEALTH INC - COMMON STOCK OFFERING AND TANGIBLE EQUITY UNIT OFFERING ARE SEPARATE PUBLIC OFFERINGS.ELANCO ANIMAL HEALTH INC - EACH TANGIBLE EQUITY UNIT HAS A STATED AMOUNT OF $50.  Full Article

Elanco Signs Agreement With PetIQ To Divest Capstar
Monday, 13 Jan 2020 

Jan 13 (Reuters) - Elanco Animal Health Inc ::PRESS RELEASE - ELANCO SIGNS AGREEMENT WITH PETIQ TO DIVEST CAPSTAR®.ELANCO ANIMAL HEALTH INC - DEAL FOR $95 MILLION IN AN ALL-CASH DEAL.ELANCO ANIMAL HEALTH INC - CAPSTAR HAD 2018 REVENUE OF $28.5 MILLION.  Full Article

Elanco Animal Health Sells Victoria, Pei, Canada Research And Development Facility
Tuesday, 24 Dec 2019 

Dec 24 (Reuters) - Elanco Animal Health Inc ::ELANCO SELLS VICTORIA, PEI, CANADA RESEARCH AND DEVELOPMENT FACILITY TO THE CENTER FOR AQUACULTURE TECHNOLOGIES CANADA (CATC).ELANCO ANIMAL HEALTH INC - FINANCIAL TERMS OF DEAL WERE NOT DISCLOSED..  Full Article

Elanco Animal Health Q2 Adjusted Earnings Per Share $0.28
Tuesday, 13 Aug 2019 

Aug 13 (Reuters) - Elanco Animal Health Inc ::ELANCO ANIMAL HEALTH REPORTS SECOND QUARTER RESULTS, INCLUDING STRONG EPS AND GROSS MARGIN IMPROVEMENT.Q2 ADJUSTED EARNINGS PER SHARE $0.28.Q2 EARNINGS PER SHARE $0.10.Q2 REVENUE $781.6 MILLION VERSUS REFINITIV IBES ESTIMATE OF $782.9 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.26 -- REFINITIV IBES DATA.SEES FY 2019 EARNINGS PER SHARE $0.36 TO $0.44.SEES FY 2019 REVENUE $3.08 BILLION TO $3.12 BILLION.SEES 2019 ADJUSTED EPS $1.04 TO $1.10.FY2019 EARNINGS PER SHARE VIEW $1.09, REVENUE VIEW $3.11 BILLION -- REFINITIV IBES DATA.EXPECTED 2019 REVENUE NOW BETWEEN $3.08 BILLION AND $3.12 BILLION, REDUCING TOP END OF RANGE BY $20 MILLION.ELANCO ANIMAL HEALTH - UPDATING FY GUIDANCE FOR REVENUE & EPS TO REFLECT INCREASED HEADWIND FROM AFRICAN SWINE FEVER.REVENUE FROM STRATEGIC EXITS INCREASED 52 PERCENT FOR QUARTER, AND REPRESENTED 4 PERCENT OF TOTAL REVENUE.  Full Article

Elanco Animal Health Aiming To Reach Agreement As Soon As Next Week To Combine With Bayer's Animal-Health Unit- Bloomberg
Wednesday, 7 Aug 2019 

Aug 7 (Reuters) - :ELANCO ANIMAL HEALTH IS AIMING TO REACH AN AGREEMENT AS SOON AS NEXT WEEK TO COMBINE WITH BAYER'S ANIMAL-HEALTH UNIT - BLOOMBERG REPORTER ON TWITTER.  Full Article

Elanco Finalizes Acquisition Of Aratana Therapeutics
Thursday, 18 Jul 2019 

July 18 (Reuters) - Elanco Animal Health Inc ::ELANCO FINALIZES ACQUISITION OF ARATANA THERAPEUTICS.ELANCO - BEGUN FORMATION OF A NEW COMMERCIAL TEAM DEDICATED TO VETERINARY SPECIALTY BUSINESS INTO WHICH ARATANA FIELD FORCE WILL TRANSITION.  Full Article

Elanco's Brazil unit taps new executive as $6.89 billion Bayer deal concluded

SAO PAULO Sérgio Schuler was appointed director general of Elanco Animal Health Inc's Brazil unit after the U.S.-based veterinary products firm completed its acquisition of Bayer's animal health division on Monday.